Berylson Capital Partners, LLC / ACRS
Berylson Capital Partners, LLC’s Aclaris Therapeutics Inc Position
Does Berylson Capital Partners, LLC own Aclaris Therapeutics Inc (ACRS)? Not currently — the last reported position was 193.9K shares worth $1M in Q1 2019; the fund’s latest 13F (Q3 2024) no longer reports it.
Position Value
$1M
Q1 2019
Shares
193.9K
% of Portfolio
+1.37%
Quarters Held
1
position exited
Position History ACRS
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2019 | 193.9K | $1M | +1.37% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Berylson Capital Partners, LLC’s full portfolio or all institutional holders of ACRS.